Early-life microbiota direct an epithelial S100 program required for neonatal immunity.

Negi S; Hashimoto-Hill S; Waddell A; Engleman L; Lutz M; Rice T; Denson LA; Vallance BA; Azouz NP; Tessier PA; Grivennikov SI; Deshmukh H; Alenghat T

doi:10.1126/scitranslmed.adx6147

Early-life microbiota direct an epithelial S100 program required for neonatal immunity.

Negi S Hashimoto-Hill S Waddell A Engleman L Lutz M Rice T Denson LA Vallance BA Azouz NP Tessier PA Grivennikov SI Deshmukh H Alenghat T

Journal: Science translational medicine • 2026 Oct 7

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

# Biomedical Sciences # Life Sciences # Medicine

How to Cite this Article

                    Negi S, Hashimoto-Hill S, Waddell A, et al. (2026). "Early-life microbiota direct an epithelial S100 program required for neonatal immunity.". Science translational medicine. https://doi.org/10.1126/scitranslmed.adx6147                

Access Full Article

Read Original Article ↗ View Source PDF ↗

MainReads is an independent discovery directory. Clicking above directs you to the official publisher repository.

Licence & Open Access

PMC Public Access (View-Only)

Publicly accessible via the publisher or archive. Commercial redistribution or automated full-text duplication without author permission may be restricted.

Identifiers & Provenance

DOI: 10.1126/scitranslmed.adx6147 ↗
PMCID: PMC13712116 ↗
PMID: 42842719 ↗
Primary Index: PMC